Observation on tissue factor pathway and some other coagulation parameters during the onset of acute cerebrocardiac thrombotic diseases

Author： He M.   Wen Z.   He X.   Xiong S.   Liu F.   Xu J.   Li J.   Xie Q.   Jian Z.   Chen F.   Xiao B.   Pu X.   He S.  

Publisher： Elsevier

ISSN： 0049-3848

Source： Thrombosis Research, Vol.107, Iss.5, 2002-09, pp. : 223-228

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibition of the Tissue Factor Coagulation Pathway

By  

Current Vascular Pharmacology, Vol. 2, Iss. 4, 2004-10 ,pp. : 319-327

Bentham Science Publishers

Access to resources Recommend Favorite

Plasma tissue factor pathway inhibitor in disseminated intravascular coagulation: comparison of its behavior with plasma tissue factor

By Takahashi H.   Sato N.   Shibata A.  

Thrombosis Research, Vol. 80, Iss. 4, 1995-11 ,pp. : 339-348

Elsevier

Access to resources Recommend Favorite

BINDING OF TISSUE FACTOR PATHWAY INHIBITOR TO CULTURED ENDOTHELIAL CELLS-INFLUENCE OF GLYCOSAMINOGLYCANS - VII: Additional pathway initiating blood coagulation

By Iversen N.   Sandset P.M.   Abildgaard U.   Torjesen P.A.  

Thrombosis Research, Vol. 84, Iss. 4, 1996-11 ,pp. : 267-278

Elsevier

Access to resources Recommend Favorite

Pharmacokinetics and delayed experimental anti-thrombotic effect of two domain non-glycosylated tissue factor pathway inhibitor.

By Holst J.   Lindblad B.   Westerlund G.   Bregengaard C.   Ezban M.   Ostergaard P.B.   Nordfang O.   Hedner U.  

Thrombosis Research, Vol. 81, Iss. 4, 1996-02 ,pp. : 461-470

Elsevier

Access to resources Recommend Favorite

Effects of different progestin regimens in hormone replacement therapy on blood coagulation factor VII and tissue factor pathway inhibitor

By Bladbjerg E.M.  

Human Reproduction, Vol. 17, Iss. 12, 2002-12 ,pp. : 3235-3241

Oxford University Press

Access to resources Recommend Favorite